Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy

The presence of opioid peptides within pancreatic islets in several animal species and in humans suggests that these peptides could play a role in pancreatic endocrine secretion, influencing glucose metabolism. We measured plasma met-enkephalin (met-Enk) levels in eight neuropathic (four with insuli...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Metabolism, clinical and experimental clinical and experimental, 1996-09, Vol.45 (9), p.1065-1068
Hauptverfasser: Fallucca, F., Tonnarini, G., Di Biase, N., D'Alessandro, M., Negri, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1068
container_issue 9
container_start_page 1065
container_title Metabolism, clinical and experimental
container_volume 45
creator Fallucca, F.
Tonnarini, G.
Di Biase, N.
D'Alessandro, M.
Negri, M.
description The presence of opioid peptides within pancreatic islets in several animal species and in humans suggests that these peptides could play a role in pancreatic endocrine secretion, influencing glucose metabolism. We measured plasma met-enkephalin (met-Enk) levels in eight neuropathic (four with insulin-dependent diabetes mellitus [IDDM] and four with non—insulin-dependent diabetes mellitus [NIDDM]) and eight nonneuropathic (four IDDM and four NIDDM) diabetic patients to study met-Enk secretion in diabetic patients with asymptomatic autonomic neuropathy. Plasma met-Enk levels were significantly lower in neuropathic compared with nonneuropathic patients both in the IDDM group (28.7 ± 4.8 v 61.6 ± 4.1 pg/mL, P < .0025) and in the NIDDM group (26.5 ± 3.6 v 44.3 ± 4.6 pg/mL, P < .0125). This study suggests that the presence of neuropathy in diabetic patients, even if asymptomatic, is associated with a significant decrease of plasma met-Enk levels, thus contributing to a worsening of metabolic control under stress conditions.
doi_str_mv 10.1016/S0026-0495(96)90004-9
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78290594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0026049596900049</els_id><sourcerecordid>78290594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-89105026ecc0974361e86832078c5e433c0f572b928cfe8aaf9dd94e610197de3</originalsourceid><addsrcrecordid>eNqFkEtLxDAQgIMo6_r4CUIPInqoJn2kGS8iiy9YUHA9h2w6xWiarkkr7L83-2CvnmZgvnl9hJwxes0o4zfvlGY8pQWUl8CvgFJapLBHxqzMs1RwSvfJeIcckqMQviJTVYKPyEhUgmWQjcnszarQqqTFPkX3jYtPZY1LLP6iDUnMaqPm2BudLFRv0PXhNnlxjR3QaUy6JlFD37mujYDDwXeR-lyekING2YCn23hMPh4fZpPndPr69DK5n6Y6F9CnAhgt44WoNYWqyDlDwUWe0UroEos817Qpq2wOmdANCqUaqGsokMf_oaoxPyYXm7kL3_0MGHrZmqDRWuWwG4KsRAa0hCKC5QbUvgvBYyMX3rTKLyWjcmVTrm3KlSoJXK5tSoh9Z9sFw7zFete11Rfr59u6ClrZxiunTdhh8ZUSOIvY3QaLTvHXoJdBm5XA2njUvaw7888hf1JykNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78290594</pqid></control><display><type>article</type><title>Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Fallucca, F. ; Tonnarini, G. ; Di Biase, N. ; D'Alessandro, M. ; Negri, M.</creator><creatorcontrib>Fallucca, F. ; Tonnarini, G. ; Di Biase, N. ; D'Alessandro, M. ; Negri, M.</creatorcontrib><description>The presence of opioid peptides within pancreatic islets in several animal species and in humans suggests that these peptides could play a role in pancreatic endocrine secretion, influencing glucose metabolism. We measured plasma met-enkephalin (met-Enk) levels in eight neuropathic (four with insulin-dependent diabetes mellitus [IDDM] and four with non—insulin-dependent diabetes mellitus [NIDDM]) and eight nonneuropathic (four IDDM and four NIDDM) diabetic patients to study met-Enk secretion in diabetic patients with asymptomatic autonomic neuropathy. Plasma met-Enk levels were significantly lower in neuropathic compared with nonneuropathic patients both in the IDDM group (28.7 ± 4.8 v 61.6 ± 4.1 pg/mL, P &lt; .0025) and in the NIDDM group (26.5 ± 3.6 v 44.3 ± 4.6 pg/mL, P &lt; .0125). This study suggests that the presence of neuropathy in diabetic patients, even if asymptomatic, is associated with a significant decrease of plasma met-Enk levels, thus contributing to a worsening of metabolic control under stress conditions.</description><identifier>ISSN: 0026-0495</identifier><identifier>EISSN: 1532-8600</identifier><identifier>DOI: 10.1016/S0026-0495(96)90004-9</identifier><identifier>PMID: 8781292</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 2 - blood ; Diabetes. Impaired glucose tolerance ; Diabetic Neuropathies - blood ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Enkephalin, Methionine - blood ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Humans ; Male ; Medical sciences ; Middle Aged</subject><ispartof>Metabolism, clinical and experimental, 1996-09, Vol.45 (9), p.1065-1068</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-89105026ecc0974361e86832078c5e433c0f572b928cfe8aaf9dd94e610197de3</citedby><cites>FETCH-LOGICAL-c389t-89105026ecc0974361e86832078c5e433c0f572b928cfe8aaf9dd94e610197de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0026049596900049$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27902,27903,65308</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3205961$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8781292$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fallucca, F.</creatorcontrib><creatorcontrib>Tonnarini, G.</creatorcontrib><creatorcontrib>Di Biase, N.</creatorcontrib><creatorcontrib>D'Alessandro, M.</creatorcontrib><creatorcontrib>Negri, M.</creatorcontrib><title>Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy</title><title>Metabolism, clinical and experimental</title><addtitle>Metabolism</addtitle><description>The presence of opioid peptides within pancreatic islets in several animal species and in humans suggests that these peptides could play a role in pancreatic endocrine secretion, influencing glucose metabolism. We measured plasma met-enkephalin (met-Enk) levels in eight neuropathic (four with insulin-dependent diabetes mellitus [IDDM] and four with non—insulin-dependent diabetes mellitus [NIDDM]) and eight nonneuropathic (four IDDM and four NIDDM) diabetic patients to study met-Enk secretion in diabetic patients with asymptomatic autonomic neuropathy. Plasma met-Enk levels were significantly lower in neuropathic compared with nonneuropathic patients both in the IDDM group (28.7 ± 4.8 v 61.6 ± 4.1 pg/mL, P &lt; .0025) and in the NIDDM group (26.5 ± 3.6 v 44.3 ± 4.6 pg/mL, P &lt; .0125). This study suggests that the presence of neuropathy in diabetic patients, even if asymptomatic, is associated with a significant decrease of plasma met-Enk levels, thus contributing to a worsening of metabolic control under stress conditions.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Diabetic Neuropathies - blood</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Enkephalin, Methionine - blood</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><issn>0026-0495</issn><issn>1532-8600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLxDAQgIMo6_r4CUIPInqoJn2kGS8iiy9YUHA9h2w6xWiarkkr7L83-2CvnmZgvnl9hJwxes0o4zfvlGY8pQWUl8CvgFJapLBHxqzMs1RwSvfJeIcckqMQviJTVYKPyEhUgmWQjcnszarQqqTFPkX3jYtPZY1LLP6iDUnMaqPm2BudLFRv0PXhNnlxjR3QaUy6JlFD37mujYDDwXeR-lyekING2YCn23hMPh4fZpPndPr69DK5n6Y6F9CnAhgt44WoNYWqyDlDwUWe0UroEos817Qpq2wOmdANCqUaqGsokMf_oaoxPyYXm7kL3_0MGHrZmqDRWuWwG4KsRAa0hCKC5QbUvgvBYyMX3rTKLyWjcmVTrm3KlSoJXK5tSoh9Z9sFw7zFete11Rfr59u6ClrZxiunTdhh8ZUSOIvY3QaLTvHXoJdBm5XA2njUvaw7888hf1JykNc</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>Fallucca, F.</creator><creator>Tonnarini, G.</creator><creator>Di Biase, N.</creator><creator>D'Alessandro, M.</creator><creator>Negri, M.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960901</creationdate><title>Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy</title><author>Fallucca, F. ; Tonnarini, G. ; Di Biase, N. ; D'Alessandro, M. ; Negri, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-89105026ecc0974361e86832078c5e433c0f572b928cfe8aaf9dd94e610197de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Diabetic Neuropathies - blood</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Enkephalin, Methionine - blood</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fallucca, F.</creatorcontrib><creatorcontrib>Tonnarini, G.</creatorcontrib><creatorcontrib>Di Biase, N.</creatorcontrib><creatorcontrib>D'Alessandro, M.</creatorcontrib><creatorcontrib>Negri, M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolism, clinical and experimental</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fallucca, F.</au><au>Tonnarini, G.</au><au>Di Biase, N.</au><au>D'Alessandro, M.</au><au>Negri, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy</atitle><jtitle>Metabolism, clinical and experimental</jtitle><addtitle>Metabolism</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>45</volume><issue>9</issue><spage>1065</spage><epage>1068</epage><pages>1065-1068</pages><issn>0026-0495</issn><eissn>1532-8600</eissn><abstract>The presence of opioid peptides within pancreatic islets in several animal species and in humans suggests that these peptides could play a role in pancreatic endocrine secretion, influencing glucose metabolism. We measured plasma met-enkephalin (met-Enk) levels in eight neuropathic (four with insulin-dependent diabetes mellitus [IDDM] and four with non—insulin-dependent diabetes mellitus [NIDDM]) and eight nonneuropathic (four IDDM and four NIDDM) diabetic patients to study met-Enk secretion in diabetic patients with asymptomatic autonomic neuropathy. Plasma met-Enk levels were significantly lower in neuropathic compared with nonneuropathic patients both in the IDDM group (28.7 ± 4.8 v 61.6 ± 4.1 pg/mL, P &lt; .0025) and in the NIDDM group (26.5 ± 3.6 v 44.3 ± 4.6 pg/mL, P &lt; .0125). This study suggests that the presence of neuropathy in diabetic patients, even if asymptomatic, is associated with a significant decrease of plasma met-Enk levels, thus contributing to a worsening of metabolic control under stress conditions.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>8781292</pmid><doi>10.1016/S0026-0495(96)90004-9</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-0495
ispartof Metabolism, clinical and experimental, 1996-09, Vol.45 (9), p.1065-1068
issn 0026-0495
1532-8600
language eng
recordid cdi_proquest_miscellaneous_78290594
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Biological and medical sciences
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 2 - blood
Diabetes. Impaired glucose tolerance
Diabetic Neuropathies - blood
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Enkephalin, Methionine - blood
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Humans
Male
Medical sciences
Middle Aged
title Plasma met-enkephalin levels in diabetic patients: Influence of autonomic neuropathy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A10%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20met-enkephalin%20levels%20in%20diabetic%20patients:%20Influence%20of%20autonomic%20neuropathy&rft.jtitle=Metabolism,%20clinical%20and%20experimental&rft.au=Fallucca,%20F.&rft.date=1996-09-01&rft.volume=45&rft.issue=9&rft.spage=1065&rft.epage=1068&rft.pages=1065-1068&rft.issn=0026-0495&rft.eissn=1532-8600&rft_id=info:doi/10.1016/S0026-0495(96)90004-9&rft_dat=%3Cproquest_cross%3E78290594%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78290594&rft_id=info:pmid/8781292&rft_els_id=S0026049596900049&rfr_iscdi=true